PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE Stock

Certificat

DE000VU980A3

Market Closed - Deutsche Boerse AG 13:44:55 2024-06-27 EDT
13.03 EUR -0.53% Intraday chart for PUT - SPRINTER OPEN END - FRESENIUS MEDICAL CARE
Current month+34.61%
1 month+30.56%
Date Price Change
24-06-27 13.03 -0.53%
24-06-26 13.1 +0.15%
24-06-25 13.08 +3.48%
24-06-24 12.64 -4.17%
24-06-21 13.19 +6.89%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 01:44 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying FRESENIUS MEDICAL CARE AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU980A
ISINDE000VU980A3
Date issued 2023-07-21
Strike 48.68
Maturity Unlimited
Parity 1 : 1
Emission price 0.59
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 18.75
Lowest since issue 1.33

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.72 EUR
Average target price
39.97 EUR
Spread / Average Target
+11.91%
Consensus